SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001385508-21-000066
Filing Date
2021-05-11
Accepted
2021-05-11 16:08:38
Documents
71
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q opnt-20210331.htm   iXBRL 10-Q 801070
2 EX-31.1 exhibit31103312021.htm EX-31.1 11532
3 EX-31.2 exhibit31203312021.htm EX-31.2 11374
4 EX-32.1 exhibit32103312021.htm EX-32.1 5618
5 EX-32.2 exhibit32203312021.htm EX-32.2 5542
  Complete submission text file 0001385508-21-000066.txt   4375799

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT opnt-20210331.xsd EX-101.SCH 40248
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT opnt-20210331_cal.xml EX-101.CAL 60264
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT opnt-20210331_def.xml EX-101.DEF 213247
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT opnt-20210331_lab.xml EX-101.LAB 450137
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT opnt-20210331_pre.xml EX-101.PRE 340308
11 EXTRACTED XBRL INSTANCE DOCUMENT opnt-20210331_htm.xml XML 518812
Mailing Address 233 WILSHIRE BLVD, SUITE 280 SUITE 500 SANTA MONICA CA 90401
Business Address 233 WILSHIRE BLVD, SUITE 280 SUITE 500 SANTA MONICA CA 90401 (310) 598-5410
OPIANT PHARMACEUTICALS, INC. (Filer) CIK: 0001385508 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38193 | Film No.: 21911339
SIC: 2834 Pharmaceutical Preparations